Caldera Medical this week announced it appointed John Pitstick as chief financial officer and executive VP of corporate development. The company said the appointment will allow it to focus on advancing Caldera’s position in the women’s health sector with M&A activity during rapid expansion. Pitstick began his career at Ernst & Young managing a global […]
Caldera Medical
Caldera launches new Desara TVez for stress urinary incontinence
Surgical product developer Caldera Medical announced today that it launched the Desara TVez as part of its Desara portfolio. Los Angeles-based Caldera’s Desara family of products includes offerings for treating stress urinary incontinence, pelvic organ prolapse and polyps. According to Caldera’s website, Desara TVez is used through the transvaginal approach with tighter trocar curve that […]
Court clears Caldera’s $12.3m transvaginal mesh settlement
A California federal judge last week approved a $12.3 million deal to settle a number of insurance claims over injuries allegedly caused by Caldera Medical’s transvaginal mesh. Caldera’s insurer, Federal Insurance Co., will distribute $10.6 million to over 2,700 class members, as well as a $670,020 payment for attorney’s fees and costs in the case. […]
Caldera Medical wins FDA 510(k) for next-gen Vertessa Lite mesh
Caldera Medical said today it won FDA 510(k) clearance for its next-generation Vertessa Lite polypropylene mesh for treating pelvic organ prolapse. The new version of the mesh is lighter, 31% stronger than other market-leading meshes and has a 32% increased suture pull out strength, the Agoura Hills, Calif.-based company said. “As part of our continuous […]